Cochlear Limited (ASX: COH) shareholders are likely to have something to cheer about today as the company pays out its latest dividend.
The hearing solutions company is set to reward eligible investors with an unfranked interim dividend of $1.55 per share.
At Wednesday’s market close, the Cochlear share price finished 1.23% higher at $227.20.
For context, the S&P/ASX 200 Index (ASX: XJO) also climbed yesterday with a slight gain of 0.05% to 7,569.2 points.
Let’s look at the details regarding the company’s dividend.
Cochlear pays interim dividend
On 22 February, Cochlear reported a robust performance in its half-year results for the 2022 financial year.
In summary, sales revenue increased 10% to $815 million compared to the prior corresponding period. This was driven by an uneven split between emerging and developed markets.
On the bottom line, Cochlear recorded a 26% lift in underlying net profit after tax (NPAT) of $158 million.
Management noted that the COVID-19 pandemic challenged the results, affecting hospital staffing levels.
Nonetheless, the board elected to bump up its interim dividend by 35% on the previous year’s first-half distribution of $1.15 per share.
Based on the current share price, Cochlear is trailing on a forecast dividend yield of 0.62%
Cochlear share price summary
Cochlear shares have nudged 5% higher over the last 12 months, buoyed by strong gains after delivering its financial scorecard. The company’s shares are up 4% this year to date.
The Cochlear share price reached a 52-week low of $178.55 in January but has regained some ground and is now trading around November 2021 levels.
Cochlear has a price-to-earnings (P/E) ratio of 57.56 and commands a market capitalisation of roughly $14.94 billion.
The post The Cochlear dividend is being paid today. Here’s what you need to know appeared first on The Motley Fool Australia.
Should you invest $1,000 in Cochlear right now?
Before you consider Cochlear, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Cochlear wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of January 13th 2022
More reading
- The Cochlear share price has shaved 13% from its all-time high. Is now the time to pounce?
- ASX 200 healthcare shares were chronically ill last quarter. Take a look
- What’s the outlook for the Cochlear share price in April?
- 3 more of the ‘best’ ASX 200 shares to buy this month: Morgans
- Why is the Cochlear (ASX:COH) share price sliding today?
Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/ZT1fzYx
Leave a Reply